CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 97 enrolled
Drug / intervention
Second-Generation Laryngeal Mask Airwaydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03748342
NCT03748342N/ACompleted
CompareCT.gov

The Use of a Second-Generation Laryngeal Mask Airway Versus Endotracheal Tube in Obese Patients

University of Texas Southwestern Medical Center·interventional·Posted Nov 20, 2018·Updated Apr 17, 2025

In Brief

A clinical study evaluating Second-Generation Laryngeal Mask Airway for Obese and 2 related conditions. Completed, enrolled 97 participants across 2 sites.

Detailed Summary

This prospective, randomized, comparative study is intended to enroll a total of 148 patients with a BMI 30-49.9 kg/m2 undergoing surgery at Parkland Hospital. The efficacy and performance of a second-generation LMA will be compared to endotracheal intubation. A standardized anesthetic protocol that is usual and customary for the type of operation the patient is having will be provided to the anesthesia teams of enrolled subjects. The remainder of the anesthetic care of the subject will not deviate from the standard of care.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObese, Endotracheal Tube, Laryngeal Mask Airway
CountriesUnited States
CollaboratorsM.D. Anderson Cancer Center

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 20, 2018
Enrollment StartJun 27, 2019
Primary CompletionFeb 2, 2024
Study CompletionFeb 3, 2025
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 7.6 years ago

Interventions

Second-Generation Laryngeal Mask Airwaydevice

A second-generation LMA will be used for airway management (instead of ETT).